Puji Budi Setia Asih 
Affiliation: Eijkman Research Centre for Molecular Biology, National Research and Innovation Agency Research proposal(s):
-
Therapeutic Efficacy Study (TES) for first line of anti-malaria drug (Dihydroartemisinin Piperaquine/DHA-PPQ) at Kupang and West Sumba districts of NTT province, Indonesia
Malaria
-
Therapeutic Efficacy Study (TES) for three antimalarial drugs (Dihydroartemisinin-Piperaquine/DHA-PPQ, Artesunate-Pyronaridine/ASPY, Artemether-Lumefantrine/AL) in Keerom and Yapen Regencies, Papua, Indonesia
Malaria